SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000770
Filing Date
2021-06-10
Accepted
2021-06-10 09:00:39
Documents
1
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 reneo_fm4jun82021.html 4  
1 reneo_fm4jun82021.xml 4 5327
  Complete submission text file 0000905718-21-000770.txt   6704
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EXICURE, INC. 8045 LAMON AVENUE, SUITE 410 SKOKIE IL 60077
Business Address
Muralidhar Bali (Reporting) CIK: 0001784138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 211007022